1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 技術別スニペット
3.3. エンドユーザー別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 痛みのない代替品への需要の増加
4.1.1.2. XX
4.1.2. 阻害要因
4.1.2.1. デバイスの高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
6.1.2. 市場魅力度指数（製品タイプ別
6.2. ハンドヘルド機器
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. ウェアラブルデバイス
7. 技術別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, 技術別
7.1.2. 市場魅力度指数、技術別
7.2. 静脈穿刺
7.2.1. 導入
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. タッチベース
8. エンドユーザー別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 外来手術センター
8.4. 診断研究所
8.5. その他
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.2.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.2.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.2.6. 市場規模分析および前年比成長率分析(%)、国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.3.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.3.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.3.6. 市場規模分析および前年比成長率分析(%)、国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. スペイン
9.3.6.5. イタリア
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.4.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.4.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.4.6. 市場規模分析および前年比成長率分析(%)、国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.5.4. 市場規模分析とYoY成長率分析（%）, 技術別
9.5.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.5.6. 市場規模分析および前年比成長率分析（%）, 国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.6.4. 市場規模分析とYoY成長率分析（%）, 技術別
9.6.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Becton, Dickinson and Company (BD) *
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*リストはありません)
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ
The Global Needle Free Blood Drawing Devices Market reached US$ 14.43 billion in 2023 and is expected to reach US$ 26.52 billion by 2031 growing with a CAGR of 7.9% during the forecast period 2024-2031.
Needle-free blood drawing devices offer a painless alternative to conventional blood collection methods that rely on needles and syringes. These devices launch a micro-particle into the skin, creating a tiny opening that allows blood to be extracted using negative pressure. This innovative technique greatly diminishes patient discomfort and lowers the likelihood of needle-stick injuries, a common issue associated with traditional blood collection methods.
The primary benefit of needle-free devices lies in their capacity to alleviate the pain associated with blood draws, addressing a significant concern for numerous patients. These devices significantly diminish the likelihood of needle-stick injuries among healthcare professionals, thereby reducing the risk of transmitting blood-borne pathogens.
Many needle-free devices are crafted to be intuitive and straightforward, making them suitable for use in home environments, which can improve patient adherence to regular health monitoring. These devices frequently utilize cutting-edge technologies, such as micro-particle propulsion or capillary action, to enable blood collection without the need for traditional needles.
Market Dynamics: Drivers
Increasing demand for pain-free alternatives
The demand for the global needle-free blood drawing devices market is driven by multiple factors. One of the primary factors is the increasing demand for pain-free alternatives. The growing preference for needle-free blood drawing devices in the U.S. is largely driven by the desire for less painful medical procedures, particularly among patients who experience anxiety or discomfort with traditional needle-based methods. This trend is significant in hospitals where a high volume of blood draws occurs, impacting clinical decisions and patient care.
Conventional blood collection techniques, like venipuncture, frequently cause considerable pain and anxiety for patients. This discomfort stems from the process of inserting needles into the skin and veins, which can be especially troubling for individuals who have a fear of needles or for those who need to undergo blood draws regularly.
Moreover, key players in the industry more focus on technological advancements that help to propel this market growth. For instance, in April 2022, the Haiim device, developed by Winnoz Technology, represents a significant advancement in blood collection methods by offering a needle-free alternative to traditional venipuncture. This innovative device is designed to collect blood samples from the fingertips, utilizing vacuum-assisted technology to draw between 150 and 500 microliters of whole blood quickly and less painfully.
Also, in February 2022, Tasso, Inc. launched Tasso Care for Prescreening, a comprehensive service solution designed to enhance the prescreening process for clinical trials. This service aims to streamline the recruitment of participants by utilizing Tasso's innovative remote blood collection technology, which is patient-centric and clinically validated.
Restraints
Factors such as the high cost of devices, limited availability of devices, and limited reimbursement policies are expected to hamper the market.
Market Segment Analysis
The global needle-free blood drawing devices market is segmented based on product type, technology, end-user, and region.
The hospital's segment accounted for approximately 65.6% of the global needle-free blood drawing devices market share
The hospital segment is expected to hold the largest market share over the forecast period. The rising frequency of blood draws conducted each year in the U.S. is fueling the demand for needle-free alternatives. In hospitals, numerous patients may require several blood draws each day, and challenges such as difficult venous access often due to obesity, age, or underlying health conditions are increasing the necessity for needle-free solutions. Hospitals play a vital role in the healthcare industry, affecting as much as 70% of clinical decisions, which underscores the importance of effective blood collection methods.
Moreover, key player’s product launches & approvals and innovative technological developments are driving this segment’s growth in this market. For instance, in November 2023, BD (Becton, Dickinson and Company) launched the PIVO Pro Needle-free Blood Collection Device after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to work with integrated catheters and aims to advance BD's vision of a "One-Stick Hospital Stay."
Similarly, YourBio Health developed the HALO Technology, created by significantly improving the blood collection process by using a patented bladeless microneedle array, which facilitates nearly painless blood draws. Also, in April 2024, the 1st generation TAP (Touch Activated Phlebotomy) device developed by YourBio Health represented a significant breakthrough in blood collection technology. It offered an easy-to-use, virtually painless alternative to traditional blood draws, making it suitable for clinical and remote clinical settings.
Market Geographical Analysis
North America accounted for approximately 46.2% of the global needle-free blood drawing devices market share
North America region is expected to hold the largest market share over the forecast period owing to the increasing demand for pain-free alternatives and a high volume of blood draws that would propel this market growth in the U.S.
Moreover, Approval from regulatory agencies such as the FDA is crucial for the promotion and utilization of needle-free blood drawing devices in the United States. Companies that can secure these approvals, like BD with its PIVO device, are positioned to gain a competitive advantage in the marketplace. In this region, a major number of key players’ presence, technological advancements, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives such as awareness programs, partnerships & collaborations are driving this market growth.
For instance, in December 2023, BD (Becton, Dickinson and Company) received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its new BD MiniDraw Capillary Blood Collection System. This innovative fingertip blood collection device is designed to collect blood samples through a fingerstick, providing a less invasive alternative to traditional venous blood draws. The system allows trained healthcare professionals to obtain lab-quality results from a smaller volume of blood, making it suitable for various common tests.
Also, in October 2022, Catapult Health and Tasso partnered to integrate the Tasso+ self-sampling blood collection device into annual healthcare checkups for employees at major corporations and national health plans in the USA. This collaboration aims to enhance the efficiency and comfort of blood testing during routine health assessments.
Market Segmentation
By Product Type
Handheld Devices
Wearable Devices
By Technology
Venipuncture
Touch-Based
By End-Users
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the needle-free blood drawing devices market include Becton, Dickinson and Company (BD), YourBio Health, Inc., Tasso, Inc., Romsons, AlphaBiolabs Ltd, Loop Medical SA., Utah Medical Products, Inc., ICU Medical, Inc., and Winnoz Technology, Inc.
Key Developments
In November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which allows blood samples to be drawn directly from a patient's peripheral IV line without using a traditional needle. This innovative device builds upon BD's existing PIVO technology that was first introduced for use with short peripheral IV catheters. The PIVO Pro is designed to be compatible with integrated catheters, including the new Nexiva Closed IV Catheter System with NearPort V Access
In March 2022, Vitestro launched an autonomous blood collection device designed to empower patients by allowing them to participate actively in their blood draw procedures. This innovative venipuncture device utilizes advanced technology, including artificial intelligence and ultrasound-guided imaging, combined with robotic needle insertion, to automate the blood collection process.
Why Purchase the Report?
To visualize the global needle-free blood drawing devices
Market Segmentation based on product type, technology, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the needle-free blood drawing devices market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.
The global needle-free blood drawing devices market report would provide approximately 59 tables, 50 figures, and 184 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product type
3.2. Snippet by Technology
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Pain-Free Alternatives
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wearable Devices
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Venipuncture *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Touch-Based
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Diagnostic Laboratories
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Becton, Dickinson and Company (BD) *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
| ※参考情報 針なし採血器具とは、従来の針を用いずに血液を採取するためのデバイスのことを指します。この器具は、痛みを軽減し、感染予防にも寄与することから、近年注目を集めています。特に、小児や高齢者などの痛みに敏感な患者にとって、針なしでの採血は大きなメリットとなります。 針なし採血器具には、いくつかの種類があります。まず代表的なのは、ジェットインジェクターという装置です。この装置は、高圧の液体やガスを用いて皮膚を貫通させ、血液を採取します。また、微細な穴を利用するデバイスも存在します。これらは、皮膚に小さな孔を開けることで血液を取り出す仕組みになっています。他にも、バイオセンサー技術を利用した、非侵襲的な血糖測定器なども針なし採血器具の一種と考えられます。 用途としては、主に血液検査に使用されます。採血が必要な検査は多岐にわたり、血液型検査、感染症のスクリーニング、血糖値やコレステロール値の測定など、さまざまな医療シーンで利用されています。また、自己管理を目的とした家庭用の検査デバイスも開発されており、糖尿病患者などが自宅で容易に血糖値を測定できるようになっています。 関連技術としては、生体医療分野の発展が挙げられます。生体材料や生理学的センサーなどの技術が進化することで、より高速で正確なデータの取得が可能になります。例えば、ナノテクノロジーを活用したデバイスは、微細なセンサーを用いて血液成分を迅速に分析することができ、医療現場での即時診断に寄与しています。 さらに、デジタル技術の進展により、データの管理や解析も容易になっています。針なし採血器具から得られたデータは、クラウドに保存されることで、医療従事者や患者がリアルタイムで情報を共有できるようになります。これにより、診断の精度が向上し、治療方針の決定にも役立っているのです。 最近では、患者のQOL（Quality of Life）を向上させる観点からも針なし採血器具の利用が勧められています。従来の採血は、出血や痛み、場合によっては血腫のリスクを伴うため、患者にとって大きな負担となります。しかし、針なし採血器具は痛みをほとんど伴わないため、患者のストレスを軽減し、医療へのリラックス感をもたらします。 なお、針なし採血器具の導入には、一部の課題も存在します。まず、従来の針を使った方法に比べて、精度や量の確保が重要なポイントとなります。特に、特定の検査においては必要な血液量が確保できない場合があり、これが医療現場での使用を制限する要因の一つとなっています。また、使用方法や器具の管理についても、従来の採血とは異なる教育やトレーニングが必要です。 このように、針なし採血器具は、従来の採血方法に比べて多くの利点がある一方、課題も含む複雑な技術です。今後の研究や開発によって、より多くの検査や診断に対応できるような進化が期待され、医療の現場での利用が広がることが望まれます。痛みの少ない、またより安全な医療を提供するための重要な手段として、針なし採血器具は確実にその地位を占めつつあるのです。 |
*** 針なし採血器具の世界市場に関するよくある質問(FAQ) ***
・針なし採血器具の世界市場規模は？
→DataM Intelligence社は2023年の針なし採血器具の世界市場規模を144億3,000万米ドルと推定しています。
・針なし採血器具の世界市場予測は？
→DataM Intelligence社は2031年の針なし採血器具の世界市場規模を265億2,000万米ドルと予測しています。
・針なし採血器具市場の成長率は？
→DataM Intelligence社は針なし採血器具の世界市場が2024年～2031年に年平均7.9%成長すると展望しています。
・世界の針なし採血器具市場における主要プレイヤーは？
→「Becton, Dickinson and Company (BD)、YourBio Health, Inc.、Tasso, Inc.、Romsons、AlphaBiolabs Ltd.、Loop Medical SA.、Utah Medical Products, Inc.、ICU Medical, Inc.、Winnoz Technology, Inc.など ...」を針なし採血器具市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
